SDS

Conditions to avoid
no data available
Incompatible materials
Acids
Ha
zardous decomposition
products
No de
composition products expected under normal conditions of use.
SECTION 11: TOXICOLOGICAL INFORMATION
Exposure ro
utes
Eye contact, Ingestion, Inhalation, Skin Absorption
Immediate Effects
Eye
Moderate eye irritation.
Skin
Harmful if absorbed throu
gh skin.
Ingestion
Harmful if swallowed.
Inhalation
Harmful if inhaled.
Information
on toxicolog
ical effects
Acute oral toxicity
LD5
0
(male/female combined rat) > 2,000 mg/kg
Acute inhalation toxicity
LC50
(male/female combined rat) > 1.2 mg/l
Exposure time: 4 h
Highest attainable concentration.
Determined in the form of a respirable aerosol.
(actual)
LC5
0
(male/female combined rat) > 4.8 mg/l
Exposure time: 1 h
Determined in the form of a respirable aerosol.
Extrapolated from the 4 hr LC50.
(actual)
Acute dermal toxicity
LD5
0
(male/female combined rat) > 4,000 mg/kg
Skin irritation
No skin irritation (rabbit)
Ey
e irritation
No eye irritation (rabbit)
Sensitisation
Non
-
sensitizing. (guinea pig)
Assessment repeated dose toxicity
The toxic effects of beta-Cyfluthrin are related to tran
sient hype
ractivity typical for pyrethroid
neurotoxicity.
Imidacloprid did not cause specific target organ toxicity in experimental animal studies.
Assessment Mutagenicity
beta-Cyfluthrin was not mutagenic or ge
notoxic in a b
attery of in vitro and in vivo tests.
Imidacloprid was not mutagenic or genotoxic based on the overall weight of evidence in a battery of in
vitro and in vivo tests.
Assessment Carcinogenicity
SBM LIFE SCIENCE CORP.
SAFETY DATA SHEET
BIOADVANCED SCIENCE-BASED
SOLUTIONS COMPLETE
BRAND ANT KILLER
PLUS† (†ALSO FOR FLEAS AND TICKS)
READY-TO-SPREAD GRANULES
Version 1.0 / USA
102000011911
6/10
Revision Date: 05/01/2017